Genome Therapeutics, Schering-Plough deal

The companies entered into a four-year collaboration to discover anti-infectives against drug-resistant organisms. Schering-Plough will pay GENE a minimum of $6 million in the first year, and up to $10 million, covering license fees, and research and milestone payments. Total payments to GENE could reach $43.5 million, excluding royalties. ...